- Home
- SKT vs ACLX Comparison
SKT vs ACLX Comparison
Compare SKT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKT
- ACLX
- Stock Information
- Founded
- SKT 1981
- ACLX 2015
- Country
- SKT United States
- ACLX United States
- Employees
- SKT 425
- ACLX N/A
- Industry
- SKT Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- SKT Real Estate
- ACLX Health Care
- Exchange
- SKT Nasdaq
- ACLX Nasdaq
- Market Cap
- SKT 3.4B
- ACLX 3.3B
- IPO Year
- SKT 1993
- ACLX 2022
- Fundamental
- Price
- SKT $30.18
- ACLX $57.55
- Analyst Decision
- SKT Buy
- ACLX Strong Buy
- Analyst Count
- SKT 9
- ACLX 14
- Target Price
- SKT $36.00
- ACLX $109.33
- AVG Volume (30 Days)
- SKT 1.1M
- ACLX 715.8K
- Earning Date
- SKT 04-30-2025
- ACLX 05-08-2025
- Dividend Yield
- SKT 3.88%
- ACLX N/A
- EPS Growth
- SKT N/A
- ACLX N/A
- EPS
- SKT 0.85
- ACLX N/A
- Revenue
- SKT $549,227,000.00
- ACLX $76,809,000.00
- Revenue This Year
- SKT $0.30
- ACLX N/A
- Revenue Next Year
- SKT $4.14
- ACLX $96.17
- P/E Ratio
- SKT $35.50
- ACLX N/A
- Revenue Growth
- SKT 12.63
- ACLX N/A
- 52 Week Low
- SKT $25.94
- ACLX $47.88
- 52 Week High
- SKT $37.57
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- SKT 42.18
- ACLX 42.15
- Support Level
- SKT $29.11
- ACLX $47.86
- Resistance Level
- SKT $32.42
- ACLX $67.36
- Average True Range (ATR)
- SKT 0.85
- ACLX 4.20
- MACD
- SKT -0.10
- ACLX -0.70
- Stochastic Oscillator
- SKT 27.16
- ACLX 49.69
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.